Novo Nordisk will cut prices of the diabetes and weight loss drugs Ozempic, Rybelsus and Wegovy to $675 effective Jan. 1, 2027.
Novo Nordisk announced up to 50% price cuts for Ozempic and Wegovy diabetes and weight-loss drugs starting January 2027, ...
The healthcare company said all doses will shift to a single monthly list price, cutting Wegovy’s price by about 50% and ...
Novo Nordisk will slash U.S. list prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 50% ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results